Report Code: CMI50433

Published Date: June 2024

Pages: 320+

Category: USA

Reports Description

US  Microfluidics Market was valued at USD 9.8 Billion in 2024 and is expected to reach USD 15.8 Billion by 2033, at a CAGR of 11.3% during the forecast period 2024 – 2033.

Microfluidics is a burgeoning field within biotechnology and biopharmaceuticals, characterized by the manipulation of tiny volumes of fluids at the microscale level.

US Microfluidics Market: Growth Factors

Growing demand for point-of-care testing

The increasing demand for point-of-care (POC) testing is a key driver propelling the growth of the microfluidics market in the United States. POC testing offers rapid and convenient diagnostic results directly at the patient’s side, eliminating the need for time-consuming laboratory processing.

This capability is particularly crucial in scenarios where timely diagnosis and treatment decisions are critical, such as in emergency rooms, clinics, and remote or resource-limited settings. Microfluidic devices play a pivotal role in enabling POC testing by miniaturizing and automating complex laboratory processes onto a small chip or cartridge.

These devices utilize microscale channels and chambers to manipulate tiny volumes of fluids, enabling precise control over sample handling, mixing, and analysis. The integration of microfluidic technology into POC testing platforms allows for faster turnaround times, reduced sample volumes, improved sensitivity and specificity, and enhanced portability compared to traditional laboratory methods.

As healthcare providers and consumers alike increasingly prioritize speed, accuracy, and accessibility in diagnostics, the demand for microfluidic-based POC testing solutions continues to rise, driving innovation and market growth within the US healthcare industry.

Miniaturization of microfluidic chips

The miniaturization of microfluidic chips has been a significant driving force behind the growth of the US microfluidics market. These chips enable the manipulation and control of small volumes of fluids within channels or chambers on a microscopic scale.

Their reduced size allows for high-throughput analysis, faster reaction times, and decreased sample and reagent consumption compared to traditional methods. This miniaturization has revolutionized various industries, including healthcare, biotechnology, and pharmaceuticals, by offering advantages such as improved sensitivity, portability, and cost-effectiveness.

In healthcare, microfluidic chips are used for point-of-care diagnostics, enabling rapid and accurate testing for diseases and pathogens with minimal sample volumes. Furthermore, the integration of multiple functionalities onto a single chip, such as sample preparation, mixing, and detection, enhances efficiency and reduces the complexity of experimental setups.

The versatility of microfluidic chips also extends to fields like drug discovery, where they facilitate high-throughput screening of compounds and the study of cellular interactions in controlled microenvironments. As a result, the demand for microfluidic devices continues to surge, driven by the need for advanced analytical tools and the pursuit of miniaturized, portable, and cost-efficient solutions across various industries.

US Microfluidics Market: Restraints

High cost

The high cost poses a significant barrier to the growth and accessibility of the microfluidics market in the United States. Microfluidics, a field focused on manipulating small volumes of fluids, holds immense potential for various industries, including healthcare, diagnostics, and biotechnology.

However, the expense associated with developing and implementing microfluidic technologies inhibits widespread adoption. Research and development costs, particularly for prototyping and testing, can be prohibitively high, deterring smaller companies and startups from entering the market.

Additionally, the production of microfluidic devices often requires specialized equipment and materials, further driving up costs. This expense is passed on to consumers, making microfluidic products less affordable for both individuals and institutions.

Consequently, the high cost limits the accessibility of microfluidic technologies, particularly in healthcare settings where cost-effectiveness is paramount. Addressing these cost barriers through technological innovation, streamlined production processes, and strategic investment in research and development could help drive down costs and unlock the full potential of microfluidics in the United States.

US Microfluidics Market: Opportunities

Development of microfluidic-based 3D cell culture systems

The development of microfluidic-based 3D cell culture systems has been a significant driver of growth in the US microfluidics market. These systems offer several advantages over traditional 2D cell cultures, including better mimicry of in vivo environments, improved cell-cell and cell-extracellular matrix interactions, and enhanced control over microenvironmental factors such as nutrient gradients and fluid flow.

This increased physiological relevance makes them invaluable tools for drug discovery, toxicity testing, and tissue engineering applications. Moreover, microfluidic-based 3D cell culture systems allow for high-throughput experimentation and precise control over experimental conditions, leading to more reproducible results and reduced costs compared to conventional methods.

As a result, they have garnered considerable attention from pharmaceutical companies, research institutions, and regulatory agencies seeking to improve drug development pipelines and reduce reliance on animal models.

Additionally, the versatility of microfluidic platforms enables integration with other analytical techniques such as imaging, sequencing, and mass spectrometry, further expanding their utility and driving adoption across various fields including biotechnology, healthcare, and diagnostics.

Consequently, the continued advancement and adoption of microfluidic-based 3D cell culture systems are poised to play a pivotal role in shaping the future of biomedical research and applications in the United States.

US Microfluidics Market: Segmentation Analysis

The US  Microfluidics market is segmented by product and technology.  Based on product, the market is classified into microfluidic-based devices and microfluidic components. Microfluidic components dominated the market in 2023 with a market share of 65.2% and are expected to keep their dominance during the forecast period 2024-2033.

Microfluidic components play a pivotal role in propelling the growth of the US microfluidics market due to their versatility, precision, and scalability. These components, which include microfluidic chips, pumps, valves, and sensors, enable the manipulation of small volumes of fluids on a microscale, offering numerous advantages in various industries such as healthcare, pharmaceuticals, biotechnology, and diagnostics.

In the healthcare sector, microfluidic components drive innovation by facilitating the development of point-of-care diagnostic devices, lab-on-a-chip systems, and personalized medicine platforms. These components enable rapid and accurate analysis of biological samples, leading to quicker diagnoses, improved treatment outcomes, and cost savings.

Moreover, the miniaturization and integration capabilities of microfluidic components enhance efficiency and throughput in drug discovery and development processes, enabling high-throughput screening, combinatorial chemistry, and controlled drug delivery.

Additionally, the increasing adoption of microfluidic components in academic research labs and biotechnology startups further drives market growth, fuelled by advancements in microfabrication techniques, materials science, and automation technologies.

As demand for miniaturized, portable, and cost-effective analytical tools continues to rise, microfluidic components are poised to play an increasingly crucial role in shaping the future of diagnostics, biotechnology, and healthcare delivery in the United States.

Based on technology, the market is classified into Lab-on-a-chip, organs-on-chips, continuous flow microfluidics, optofluidics and microfluidics, acoustofluidics and microfluidics and electrophoresis and microfluidics. Lab-on-a-chip dominated the market in 2023 with a market share of 24.1% and is expected to keep its dominance during the forecast period 2024-2033.

The emergence of lab-on-a-chip (LOC) technology has propelled significant growth within the US microfluidics market by revolutionizing the capabilities of analytical and diagnostic processes. These miniature devices integrate multiple laboratory functions onto a single chip-scale platform, enabling precise manipulation and analysis of minute fluid volumes.

LOC systems offer advantages such as rapid analysis, reduced sample and reagent consumption, enhanced portability, and automation potential. These attributes make them highly attractive across diverse fields including healthcare, environmental monitoring, and drug development.

In healthcare, LOC devices enable point-of-care diagnostics, empowering healthcare professionals with rapid and accurate results for diseases ranging from infectious diseases to cancer biomarker detection. Moreover, the versatility of microfluidic platforms allows for the development of personalized medicine approaches and advancements in genetic analysis.

The expanding adoption of LOC technology is also bolstered by ongoing innovations in materials science, manufacturing techniques, and integration with complementary technologies like sensors and data analytics. As a result, the US microfluidics market is experiencing robust growth, driven by the increasing demand for miniaturized, portable, and cost-effective analytical solutions across a spectrum of industries.

Report Scope

Feature of the Report Details
Market Size in 2024 USD 9.8 Billion
Projected Market Size in 2033 USD 15.8 Billion
Market Size in 2023 USD 9.4 Billion
CAGR Growth Rate 11.3% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Product, Technology and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Country Scope US
Buying Options Request tailored purchasing options to fulfil your requirements for research.

US Microfluidics Market: Recent Developments

  • In March 2024, Bio-Rad Laboratories received approval from AOAC International for its dd-Check STEC Solution. This solution, the first of its kind to use the Droplet Digital PCR Method, is designed to detect and confirm the presence of virulence genes from Shiga toxin-producing Escherichia coli (STEC) in raw beef trim, fresh spinach, and carcass sampling cloths. The approval indicates that the dd-Check STEC Solution is aligned with the standard reference method for confirming STEC.
  • In January 2024, Standard BioTools Inc. (Nasdaq: LAB), a company committed to propelling advancements in human health, declared the completion of its merger with SomaLogic. This merger has resulted in forming a leading entity in the field of research, providing unique multi-omics tools.
  • In March 2023, PerkinElmer Inc. announced the successful completion of the divestiture of its Applied, Food, and Enterprise Services businesses. New Mountain Capital, a firm focused on growth-oriented investments, acquired these businesses.
  • In August 2022, Thermo Fisher Scientific, a global pioneer in scientific services, unveiled its Applied Biosystems HIV-1 Genotyping Kit with Integrase. This kit, intended solely for research purposes, scrutinizes samples testing positive for the human immunodeficiency virus (HIV). Its primary function is to detect genetic variations that exhibit resistance to standard antiretroviral treatments.

List of the prominent players in the US Microfluidics Market:

  • Illumina Inc.
  • Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Abbott
  • Thermo Fisher Scientific
  • Standard BioTools
  • Others

These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.

The US Microfluidics Market is segmented as follows:

By Product Type

  • Microfluidic-based devices
  • Microfluidic Components
    • Microfluidic Chips
    • Flow & Pressure Sensors
    • Flow & Pressure Controllers
    • Microfluidic Valves
    • Micropumps
    • Microneedles
    • Other Components
  • Material
    • Silicon
    • Polymer
    • Glass

By Application

  • In-vitro Diagnostics
    • Clinical Diagnostics
    • Point-of-care Testing
    • Veterinary Diagnostics
  • Pharmaceutical & Life Science Research and Manufacturing
    • Lab Analytics
      • Proteomics
      • Genomics
      • Cell-based Assays
      • Capillary Electrophoresis
    • Microdispensing
    • Microreaction
  • Therapeutics
    • Drug delivery
    • Wearable devices

By End User

  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes
  • Pharmaceutical and biotechnology Companies

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1 US Microfluidics Market, (2024 – 2033) (USD Billion)
    • 2.2 US Microfluidics Market: snapshot
  • Chapter 3. US Microfluidics Market – Industry Analysis
    • 3.1 US Microfluidics Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Growing demand for point-of-care testing
      • 3.2.2 Miniaturization of microfluidic chips
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market Attractiveness Analysis By Product
      • 3.7.2 Market Attractiveness Analysis By Technology
  • Chapter 4. US Microfluidics Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 US Microfluidics Market: company market share, 2023
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, collaboration, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. US Microfluidics Market – Product Analysis
    • 5.1 US Microfluidics Market Overview: By Product
      • 5.1.1 US Microfluidics Market share, By Product, 2023 and 2033
    • 5.2 Microfluidic-Based Devices
      • 5.2.1 US Microfluidics Market by Microfluidic-Based Devices, 2024 – 2033 (USD Billion)
    • 5.3 Microfluidic Components
      • 5.3.1 US Microfluidics Market by Microfluidic Components, 2024 – 2033 (USD Billion)
  • Chapter 6. US Microfluidics Market – Technology Analysis
    • 6.1 US Microfluidics Market Overview: By Technology
      • 6.1.1 US Microfluidics Market Share, By Technology, 2023 and 2033
    • 6.2 Lab-on-a-chip
      • 6.2.1 US Microfluidics Market by Lab-on-a-chip, 2024 – 2033 (USD Billion)
    • 6.3 Organs-on-chips
      • 6.3.1 US Microfluidics Market by Organs-on-chips, 2024 – 2033 (USD Billion)
    • 6.4 Continuous Flow Microfluidics
      • 6.4.1 US Microfluidics Market by Continuous Flow Microfluidics, 2024 – 2033 (USD Billion)
    • 6.5 Optofluidics and Microfluidics
      • 6.5.1 US Microfluidics Market by Optofluidics and Microfluidics, 2024 – 2033 (USD Billion)
    • 6.6 Acoustofluidics and Microfluidics
      • 6.6.1 US Microfluidics Market by Acoustofluidics and Microfluidics, 2024 – 2033 (USD Billion)
    • 6.7 Electrophoresis and Microfluidics
      • 6.7.1 US Microfluidics Market by Electrophoresis and Microfluidics, 2024 – 2033 (USD Billion)
  • Chapter 7. US Microfluidics Market – Regional Analysis
    • 7.1 US Microfluidics Market Regional Overview
    • 7.2 US Microfluidics Market Share, by Region, 2023 & 2033 (USD Billion)
  • Chapter 8. Company Profiles
    • 8.1 Illumina Inc.
      • 8.1.1 Overview
      • 8.1.2 Financials
      • 8.1.3 Product Portfolio
      • 8.1.4 Business Strategy
      • 8.1.5 Recent Developments
    • 8.2 F. Hoffmann-La Roche Ltd.
      • 8.2.1 Overview
      • 8.2.2 Financials
      • 8.2.3 Product Portfolio
      • 8.2.4 Business Strategy
      • 8.2.5 Recent Developments
    • 8.3 PerkinElmer Inc.
      • 8.3.1 Overview
      • 8.3.2 Financials
      • 8.3.3 Product Portfolio
      • 8.3.4 Business Strategy
      • 8.3.5 Recent Developments
    • 8.4 Agilent Technologies Inc.
      • 8.4.1 Overview
      • 8.4.2 Financials
      • 8.4.3 Product Portfolio
      • 8.4.4 Business Strategy
      • 8.4.5 Recent Developments
    • 8.5 Bio-Rad Laboratories Inc.
      • 8.5.1 Overview
      • 8.5.2 Financials
      • 8.5.3 Product Portfolio
      • 8.5.4 Business Strategy
      • 8.5.5 Recent Developments
    • 8.6 Danaher Corporation
      • 8.6.1 Overview
      • 8.6.2 Financials
      • 8.6.3 Product Portfolio
      • 8.6.4 Business Strategy
      • 8.6.5 Recent Developments
    • 8.7 Abbott
      • 8.7.1 Overview
      • 8.7.2 Financials
      • 8.7.3 Product Portfolio
      • 8.7.4 Business Strategy
      • 8.7.5 Recent Developments
    • 8.8 Thermo Fisher Scientific
      • 8.8.1 Overview
      • 8.8.2 Financials
      • 8.8.3 Product Portfolio
      • 8.8.4 Business Strategy
      • 8.8.5 Recent Developments
    • 8.9 Standard BioTools
      • 8.9.1 Overview
      • 8.9.2 Financials
      • 8.9.3 Product Portfolio
      • 8.9.4 Business Strategy
      • 8.9.5 Recent Developments
    • 8.10 Others.
      • 8.10.1 Overview
      • 8.10.2 Financials
      • 8.10.3 Product Portfolio
      • 8.10.4 Business Strategy
      • 8.10.5 Recent Developments
List Of Figures

Figures No 1 to 17

List Of Tables

Tables No 1 to 2

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2033

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2033
  • Market revenue estimates and forecasts up to 2033, by technology
  • Market revenue estimates and forecasts up to 2033, by application
  • Market revenue estimates and forecasts up to 2033, by type
  • Market revenue estimates and forecasts up to 2033, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Prominent Player

  • Illumina Inc.
  • Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Abbott
  • Thermo Fisher Scientific
  • Standard BioTools
  • Others

FAQs

The restraints of the US  Microfluidics market is high cost.

The major driver for the US Microfluidics market is growing demand for point-of-care testing and miniaturization of microfluidic chips.

The “Microfluidic-Based Devices” category dominated the market in 2023.

The key players in the market are Illumina Inc., F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Abbott, Thermo Fisher Scientific, Standard BioTools, Others.

The market is projected to grow at a CAGR of 11.3% during the forecast period, 2024-2033.

The US Microfluidics Market size was valued at USD 9.8 Billion in 2024.

PURCHASE OPTIONS

$

2890


$

3890


$

4890


$

1890


$

2290

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • Report in your Language.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Report in your Language.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • In-Depth Company Profiles.
  • SWOT Analysis.
  • Identify your Competitors.
  • Recent Development Analysis.
  • Competitor Pricing Strategies.
  • Competitor Marketing Strategies.
  • Competitor Positioning and Messaging.
  • Competitor Product’s Strengths.
  • Free 20% or 10 Hours of Customisation.
  • 15% Discount on your Next Purchase.
  • Upgradable to other licenses.
  • PDF Format.
  • Permission to Print the Report.

Want to customize this report?
100% FREE CUSTOMIZATION!